Analysts Set Quanterix Corporation (NASDAQ:QTRX) PT at $11.75

Shares of Quanterix Corporation (NASDAQ:QTRX) have been given an average recommendation of “Hold” by the six research firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $11.75.

A number of research firms recently issued reports on QTRX. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quanterix in a report on Saturday. Canaccord Genuity Group reissued a “hold” rating and set a $5.00 price target (down from $12.00) on shares of Quanterix in a report on Monday, August 11th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Invenomic Capital Management LP bought a new stake in Quanterix during the 1st quarter worth approximately $5,872,000. Balyasny Asset Management L.P. increased its stake in Quanterix by 1,625.2% in the second quarter. Balyasny Asset Management L.P. now owns 767,801 shares of the company’s stock valued at $5,106,000 after acquiring an additional 723,295 shares during the last quarter. Blue Water Life Science Advisors LP grew its stake in shares of Quanterix by 157.3% during the second quarter. Blue Water Life Science Advisors LP now owns 957,747 shares of the company’s stock valued at $6,369,000 after buying an additional 585,572 shares during the last quarter. Trium Capital LLP bought a new stake in shares of Quanterix in the first quarter worth about $3,642,000. Finally, Ameriprise Financial Inc. lifted its holdings in Quanterix by 14.0% in the second quarter. Ameriprise Financial Inc. now owns 4,236,877 shares of the company’s stock worth $28,175,000 after buying an additional 521,639 shares during the period. 86.48% of the stock is owned by institutional investors and hedge funds.

Quanterix Price Performance

Shares of NASDAQ:QTRX opened at $5.72 on Thursday. The stock has a market capitalization of $265.81 million, a price-to-earnings ratio of -3.14 and a beta of 1.07. The business’s fifty day moving average price is $5.23 and its two-hundred day moving average price is $5.48. Quanterix has a fifty-two week low of $4.05 and a fifty-two week high of $15.67.

Quanterix (NASDAQ:QTRX) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.47) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by ($0.06). Quanterix had a negative net margin of 56.04% and a negative return on equity of 18.41%. The firm had revenue of $24.48 million for the quarter, compared to analyst estimates of $29.73 million. Quanterix has set its FY 2025 guidance at EPS. Research analysts expect that Quanterix will post -0.98 EPS for the current fiscal year.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.